Financials AXA

Equities

CS

FR0000120628

Life & Health Insurance

Market Closed - Euronext Paris 16:35:04 18/07/2024 BST After market 18:56:25
32.25 EUR +0.84% Intraday chart for AXA 32.21 -0.12%

Valuation

Fiscal Period: December 2019 2020 2021 2022 2023 2024 2025 2026
Capitalization 1 60,384 46,637 62,576 62,187 64,437 70,393 - -
Enterprise Value (EV) 1 51,536 90,842 59,292 94,301 96,039 83,793 83,793 83,793
P/E ratio 16.6 x 15.6 x 8.82 x 9.21 x 9.42 x 9.21 x 8.42 x 7.85 x
Yield 5.69% 7.33% 5.88% 6.52% 6.71% 6.7% 7.24% 7.74%
Capitalization / Revenue 0.58 x 0.48 x 0.63 x 0.61 x 0.77 x 0.66 x 0.63 x 0.61 x
EV / Revenue 0.5 x 0.94 x 0.59 x 0.92 x 1.15 x 0.78 x 0.75 x 0.72 x
EV / EBITDA - - - - - - - -
EV / FCF 6.14 x 3.61 x 9.6 x 12.5 x 16 x 13.9 x 13.1 x 12.5 x
FCF Yield 16.3% 27.7% 10.4% 7.98% 6.26% 7.2% 7.61% 8.01%
Price to Book 0.86 x 0.65 x 0.96 x 1.49 x 1.3 x 1.41 x 1.34 x 1.27 x
Nbr of stocks (in thousands) 2,404,779 2,390,174 2,389,774 2,386,757 2,185,051 2,201,172 - -
Reference price 2 25.11 19.51 26.18 26.06 29.49 31.98 31.98 31.98
Announcement Date 20/02/20 25/02/21 24/02/22 23/02/23 22/02/24 - - -
1EUR in Million2EUR
Estimates

Income Statement Evolution (Annual data)

Fiscal Period: December 2019 2020 2021 2022 2023 2024 2025 2026
Net sales 1 103,532 96,723 99,931 102,345 83,627 107,168 111,982 116,311
EBITDA - - - - - - - -
EBIT 1 5,841 4,264 9,514 9,329 9,218 9,467 10,200 11,218
Operating Margin 5.64% 4.41% 9.52% 9.12% 11.02% 8.83% 9.11% 9.64%
Earnings before Tax (EBT) 1 5,014 4,872 9,196 8,710 8,886 9,469 9,927 10,591
Net income 1 3,860 3,164 7,294 6,675 7,189 7,814 8,382 8,767
Net margin 3.73% 3.27% 7.3% 6.52% 8.6% 7.29% 7.48% 7.54%
EPS 2 1.510 1.250 2.970 2.830 3.130 3.471 3.800 4.074
Free Cash Flow 1 8,399 25,145 6,176 7,528 6,010 6,037 6,375 6,714
FCF margin 8.11% 26% 6.18% 7.36% 7.19% 5.63% 5.69% 5.77%
FCF Conversion (EBITDA) - - - - - - - -
FCF Conversion (Net income) 217.59% 794.72% 84.67% 112.78% 83.6% 77.26% 76.06% 76.59%
Dividend per Share 2 1.430 1.430 1.540 1.700 1.980 2.142 2.315 2.475
Announcement Date 20/02/20 25/02/21 24/02/22 23/02/23 22/02/24 - - -
1EUR in Million2EUR
Estimates

Income Statement Evolution (Quarterly data)

Fiscal Period: December 2019 S2 2020 S1 2020 S2 2021 S1 2021 S2 2022 Q1 2022 S1 2022 S2 2023 S1 2024 S1
Net sales 1 - 52,391 - 53,865 46,066 23,294 55,141 47,204 40,715 -
EBITDA - - - - - - - - - -
EBIT - 1,885 2,379 - - - - - - -
Operating Margin - 3.6% - - - - - - - -
Earnings before Tax (EBT) - - 2,552 - - - - - - -
Net income - 1,429 - 3,996 - - 4,108 2,567 3,833 3,828
Net margin - 2.73% - 7.42% - - 7.45% 5.44% 9.41% -
EPS 0.5900 0.5600 - 1.630 1.340 - 1.730 1.100 - -
Dividend per Share - - - - - - - - - -
Announcement Date 20/02/20 06/08/20 25/02/21 02/08/21 24/02/22 03/05/22 03/08/22 23/02/23 03/08/23 -
1EUR in Million
Estimates

Balance Sheet Analysis

Fiscal Period: December 2019 2020 2021 2022 2023 2024 2025 2026
Net Debt 1 - 44,205 - 32,114 31,602 13,400 13,400 13,400
Net Cash position 1 8,848 - 3,284 - - - - -
Leverage (Debt/EBITDA) - - - - - - - -
Free Cash Flow 1 8,399 25,145 6,176 7,528 6,010 6,037 6,375 6,714
ROE (net income / shareholders' equity) 5.83% 4.47% 14.7% 12.8% 14.1% 15.6% 16% 16.2%
ROA (Net income/ Total Assets) 0.45% 0.58% 0.86% 0.99% 1.12% 1.18% 1.22% 1.29%
Assets 1 855,686 545,029 852,202 676,408 641,417 662,481 685,048 677,480
Book Value Per Share 2 29.30 30.00 27.40 17.50 22.70 22.60 23.80 25.20
Cash Flow per Share - 10.70 - - - - - -
Capex 1 - - - - - - - -
Capex / Sales - - - - - - - -
Announcement Date 20/02/20 25/02/21 24/02/22 23/02/23 22/02/24 - - -
1EUR in Million2EUR
Estimates

EPS & Dividend

Year-on-year evolution of the PER

Year-on-year evolution of the Yield

Change in Enterprise Value/EBITDA

Trading Rating
Investor Rating
ESG Refinitiv
B-
More Ratings
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
17
Last Close Price
31.98 EUR
Average target price
38.46 EUR
Spread / Average Target
+20.25%
Consensus